Please login to the form below

Not currently logged in

Pharmaceutical Market Europe - September 2013

PME July/August 2013In this issue we talk with …

Ariad's Harvey Berger and Timothy Clackson
Who discuss building a sustainable biotech business and following their own path

And we take a look at …

Personalised cancer medicines
As our knowledge of the area improves the oncology and orphan drugs worlds are drawn ever closer …

The science of decision making
Gaining an insight into the way people think can provide a major competitive advantage …  

Chinese healthcare reforms
The impact of tighter regulations and an emerging domestic industry on global pharma companies …

Has Portugal fallen out of love with branded medicines
The deep recession and debt crisis has led to sustained growth in the country's use of generics … 

Communicating value with patient adherence programmes
Delivering 'beyond the pill' to provide extra benefits for physicians, payers, patients and regulators …   

Also with this issue …

The megingococcal b research pipeline
The approval of the first vaccine in the form of Novartis' Bexsero represents a major milestone

Translational pharmacology
Early access and regulation in rare diseasesA masterclass on ways to boost clinical trial success rates

European pharma job cuts are releasing talent that's driving the development of bioclusters …

and in addition ...

... Early access and regulation in rare diseases
PME's next Orphan Drugs and Rare Diseases supplement tackles how to meet patient needs …



View PME September 2013 online

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone, iPad, Android and Kindle Fire

Please note: Some older digital editions may no longer be accessible while we transition to a new digital edition system and app -

COVID-19 Updates and Daily News

Featured jobs


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...